The archive
137 stories from 60 issues. Filter by industry, type of news, date or company, and choose how much to read.
Type of news
Industry
6 stories
- 17 NovNew
Launch
OpenAI's healthcare ChatGPT now operates clinical software for staffWhy it matters If you run a healthcare organisation, you can now pilot AI on admin work across your existing software, not only Q&A.
Impact Healthcare organisations can pilot agents that operate their software to cut admin workload.
- 4 NovNew
Launch
Google's AI helper cuts a days-long drug design cycle to about an hourWhy it matters Drug discovery teams can cut one design-and-data cycle from several days to about an hour, based on Google DeepMind's lung cancer demo.
Impact Drug design cycles shrink from days to about an hour with AI agents.
- 4 NovNew
Programme
Barnsley care, building and small firms get £800,000 of funded AI training for staffWhy it matters Barnsley employers in care, construction and small business can get funded AI training for staff, with the pilot's results possibly shaping national schemes.
Impact Local care and construction employers can access funded AI training for their staff.
- 21 OctNew
Funding
OpenAI buys Orchestra Bio to bring AI into drug development workWhy it matters Biopharma teams now have OpenAI heading into their R&D operations, so reassess any AI workflow vendors you rely on.
Impact Drug developers gain OpenAI-run AI for R&D operations, competing with existing workflow vendors.
- 16 OctNew
Programme
OpenAI is giving university biology labs sponsored access to its science AIWhy it matters Life sciences startups now compete for academic talent and partnerships with labs that get OpenAI's GPT-Rosalind through a sponsored plan.
Impact Qualifying university biology labs get funded access to GPT-Rosalind and supporting tools.
- 16 OctNewGoogle's AI platform helped scientists find a possible new antibiotic candidate, still untested in labs
Why it matters Drug discovery teams can run a multi-database target search in one agent session, but the lead is only predicted, not lab-confirmed.
Impact Agent platforms can scan protein databases for antibiotic leads, still awaiting lab validation.